Shelby Houlihan signs with Skechers after doping ban — image accompanying Canadian Running's report. Image accompanying Canadian Running’s report; reduced and presented for news commentary with the attributed report. View the complete source report.
Shelby Houlihan, 33, has signed with Skechers, her first shoe sponsor since a doping ban. The American runner was suspended for four years starting in 2021. Houlihan aims for the 2027 World Championships and 2028 Olympics.
Skechers gains a high-profile athlete to represent its AERO line. Houlihan is the first athlete for the line, following a previous partnership with Meb Keflezighi. The AERO range is designed for various running needs. Read more gear coverage.
Houlihan's ban stemmed from a positive test for nandrolone in 2020. She maintains the result was due to contaminated food. The CAS ruled against her, enforcing a four-year ineligibility period. Related: Salomon to sponsor Ironman World Championship from 2027.
This original Runner World brief is based on reporting from Canadian Running. Visit the source for its complete reporting, context and any later corrections.
Reader questions
Questions about this report
What should runners know about Shelby Houlihan signs with Skechers after doping ban?
Houlihan joins Skechers, marking a comeback after a four-year suspension. Shelby Houlihan, 33, has signed with Skechers, her first shoe sponsor since a doping ban. The American runner was suspended for four years starting in 2021. Houlihan aims for the 2027 World Championships and 2028 Olympics.
When did Runner World publish this gear brief?
Runner World published this brief on September 18, 2026. The underlying Canadian Running report was dated September 18, 2026.
Where can readers find the complete original report?
This summary is based on reporting from Canadian Running. The attributed source link in the article leads to the publisher’s complete report.
THE WEEKLY BRIEFING
Start the week a step ahead.
A concise edit of the running stories worth knowing, sent every Monday.
